Haemonetics Corp (NYSE:HAE)

75.89
Delayed Data
As of Oct 03
 +0.03 / +0.04%
Today’s Change
43.50
Today|||52-Week Range
79.45
+43.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Revenue and IncomeNet Revenues908.8M886.1M903.9M967.6M
 
 
 
 
 
Cost of Goods Sold404.2M401.4M400.9M401.5M
 
 
 
 
 
Depreciation And Amortization89.9M89.7M89.2M109.4M
 
 
 
 
 
 
Operating ExpensesGross Income414.7M395.0M413.8M456.7M
 
 
 
 
 
General Expenses319.9M299.7M310.0M320.4M
 
 
 
 
 
Research And Development45.0M37.6M39.2M35.7M
 
 
 
 
 
Total Operating Expenses814.0M790.9M800.1M831.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income94.8M95.3M103.8M136.3M
 
 
 
 
 
Extraordinary Credit4.7M857.0K--1.4M
 
 
 
 
Extraordinary Charge-143.6M-109.4M-46.7M-52.8M
 
 
 
 
 
Interest Expense On Debt8.5M9.0M4.5M11.6M
 
 
 
 
 
Other Expenses-873.0K-5.2M6.7M0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-53.4M-27.5M59.6M73.6M
 
 
 
 
 
Income Taxes-2.2M-1.2M-14.1M-18.6M
 
 
 
 
 
Net Income-55.6M-26.3M45.6M55.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.9M51.5M52.8M51.5M
 
 
 
 
 
Shares To Calculate EPS Diluted50.9M51.5M53.5M52.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.09-$0.51$0.85$1.04
 
 
 
 
 
EPS Diluted-$1.09-$0.51$0.85$1.04